We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-2.08%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$971M
AUM Growth
-$166M
Cap. Flow
-$152M
Cap. Flow %
-15.64%
Top 10 Hldgs %
19.56%
Holding
242
New
33
Increased
69
Reduced
52
Closed
50

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$13.3M
2
GH icon
Guardant Health
GH
+$10.1M
3
NCLH icon
Norwegian Cruise Line
NCLH
+$8.18M
4
EXLS icon
EXL Service
EXLS
+$7.81M
5
RSI icon
Rush Street Interactive
RSI
+$7.55M

Top Sells

Rank Stock Value
1
EVR icon
Evercore
EVR
+$20M
2
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$14.8M
3
TFII icon
TFI International
TFII
+$14.5M
4
CORZ icon
Core Scientific
CORZ
+$13.4M
5
FTAI icon
FTAI Aviation
FTAI
+$12.9M

Sector Composition

Rank Sector Weight
1 Industrials 20.23%
2 Technology 20.07%
3 Healthcare 16.69%
4 Consumer Discretionary 9.79%
5 Financials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRAX icon
201
Praxis Precision Medicines
PRAX
$10.1B
– –
-8,481
Closed -$653K
PRCT icon
202
Procept Biorobotics
PRCT
$1.17B
– –
-68,137
Closed -$5.49M
QQQ icon
203
Invesco QQQ Trust
QQQ
$481B
– –
-7,123
Closed -$3.64M
RGEN icon
204
Repligen
RGEN
$9.25B
– –
-5,587
Closed -$804K
RNAM
205
DELISTED
Avidity Biosciences
RNAM
– –
-69,570
Closed -$2.02M
ROST icon
206
Ross Stores
ROST
$81.9B
– –
-6,988
Closed -$1.06M
SG icon
207
Sweetgreen
SG
$642M
– –
-162,019
Closed -$5.19M
SPY icon
208
State Street SPDR S&P 500 ETF Trust
SPY
$810B
– –
-15,515
Closed -$9.09M
TFII icon
209
TFI International
TFII
$11.5B
– –
-107,291
Closed -$14.5M
TOL icon
210
Toll Brothers
TOL
$14.5B
– –
-3,608
Closed -$454K
TPG icon
211
TPG
TPG
$7.86B
– –
-66,689
Closed -$4.19M
VRTX icon
212
Vertex Pharmaceuticals
VRTX
$126B
– –
-1,218
Closed -$490K
WFRD icon
213
Weatherford International
WFRD
$6.22B
– –
-76,653
Closed -$5.49M
WT icon
214
WisdomTree
WT
$3.22B
– –
-726,427
Closed -$7.63M
LOAR icon
215
Loar Holdings
LOAR
$6.64B
– –
-40,920
Closed -$3.02M
XYZ
216
Block Inc
XYZ
$47.5B
– –
-20,208
Closed -$1.72M
ATSG
217
DELISTED
Air Transport Services Group
ATSG
– –
-16,834
Closed -$370K
ITCI
218
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-176,870
Closed -$14.8M
5 6 7 8
9

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Nicholas Investment Partners held 242 positions worth $971M, down 15% from $1.14B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Investment Partners withdrew a net $152M in Q1 2025, closing 50 positions and reducing 52 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in State Street Health Care Select Sector SPDR ETF worth $13.4M.

  • Nicholas Investment Partners's largest Q1 2025 buy was State Street Health Care Select Sector SPDR ETF: 91,756 shares worth $13.4M.
  • Nicholas Investment Partners added most to Rush Street Interactive in Q1 2025, an estimated $7.55M increase.
  • Nicholas Investment Partners's biggest Q1 2025 reduction was Evercore, cutting an estimated $20M.
  • Nicholas Investment Partners fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $14.8M.
  • Nicholas Investment Partners's ten largest holdings make up 20% of its $971M portfolio in Q1 2025.
  • Nicholas Investment Partners opened 33 new positions and closed 50 in Q1 2025.
  • Nicholas Investment Partners's portfolio value fell 15% quarter-over-quarter to $971M.

Based on Nicholas Investment Partners's 13F filing for Q1 2025, filed 15 May 2025.